WHITEPAPER: BLIS K12™ ENHANCES IMMUNE DEFENCES AND REDUCES THE SYMPTOMS OF COVID-19
In our latest whitepaper, a recent study shows that BLIS K12™ stimulates the production of antibodies specific to SARS CoV-2 virus in people that have been vaccinated for COVID-19 and led to accelerated viral clearance.